| Literature DB >> 33638248 |
Rasha Al-Hamdan1,2, Amanda Avery1, Dara Al-Disi2, Shaun Sabico3, Nasser M Al-Daghri3, Fiona McCullough1.
Abstract
AIMS/Entities:
Keywords: Arab women; Diabetes prevention; Social media
Mesh:
Substances:
Year: 2021 PMID: 33638248 PMCID: PMC8504913 DOI: 10.1111/jdi.13531
Source DB: PubMed Journal: J Diabetes Investig ISSN: 2040-1116 Impact factor: 4.232
Figure 1Flow chart of participants. CG, control group; GEP, group education program; WEP, WhatsApp education program.
Interventions given to groups.
| Lifestyle Intervention | CG | GEP | WEP |
|---|---|---|---|
|
Baseline Reduce weight (5% from baseline weight) Moderate exercise (150 min/week) Reduce fat intake (30% of total energy and saturated fat 10% of total energy) Increase fiber intake (15 g/1,000 kcal) diet | Given as a booklet to the group | Explained by registered dietitian individually | Delivered through WhatsApp group |
| Bimonthly lifestyle education sessions for 3 months | None | ✓ | ✓ |
| Dietary counseling | None | Every 2 weeks for 3 months, then continue to follow up until the 6‐month period | Every 2 weeks for 3 months, (via WhatsApp), then continue to follow up until the 6‐month period |
| Dietary intake record | Baseline, and after 3 and 6 months | ||
| Physical activity record questionnaire | Baseline, and after 3 and 6 months | ||
| Mode of follow up | Group | Group | Group |
| On demand support system | None | ✓ | ✓ |
| Blood extraction | Baseline and after 6 months | ||
| Anthropometrics | Baseline, and after 3 and 6 months | ||
CG, control group; GEP, group educational program; WEP, WhatsApp educational program.
Demographic and clinical characteristics of participants (completers)
| Parameter | CG | GEP | WEP |
|
|---|---|---|---|---|
|
| 37 | 40 | 43 | |
| Age (years) | 50.9 ± 7.1 | 42.9 ± 12.2* | 43.7 ± 8.1* | <0.001 |
| Marital status | ||||
| Divorced | 2 (6.3) | 2 (5.4) | 3 (9.1) | 0.001 |
| Married | 22 (68.8) | 19 (51.3) | 29 (87.9)** | |
| Single | 2 (6.3) | 12 (32.4)* | 1 (3.0)** | |
| Widow | 6 (18.8) | 1 (2.7) | 0A | |
| Married to relative? | ||||
| No | 27 (67.5) | 32 (86.4) | 36 (83.7) | 0.14 |
| Yes | 13 (32.5) | 5 (13.6) | 7 (16.3) | |
| Consanguinity | ||||
| 1st degree | 1 (11.1) | 5 (83.3)* | 2 (28.6) | 0.013 |
| 2nd degree | 8 (88.9) | 1 (16.7)* | 5 (71.4) | |
| Family history | ||||
| Diabetes | 29 (72.5) | 18 (45)* | 22 (55) | 0.04 |
| Hypertension | 10 (25) | 14 (35) | 7 (17.5) | 0.20 |
| Hyperlipidemia | 6 (15) | 7 (17.5) | 6 (15) | 1.00 |
| Asthma | 5 (12.5) | 8 (20) | 3 (7.5) | 0.29 |
| Obesity | 4 (10) | 10 (25) | 6 (15) | 0.23 |
| Coronary heart | 3 (7.5) | 5 (12.5) | 1 (2.5) | 0.29 |
| Medical history | ||||
| Diabetes | 0 | 0 | 1 (2.5) | 1.00 |
| Asthma | 0 | 0 | 1 (2.5) | – |
| Coronary heart | 0 | 0 | 1 (2.5) | – |
|
| 1.00 | |||
| Cancer | 0 | 1 (2.5) | 0 | |
| Liver disease | 0 | 0 | 0 | 1.00 |
| Kidney disease | 0 | 0 | 1 (2.5) | – |
|
| 1.00 | |||
| Anemia | 1 (2.5) | 0 | 0 | |
| Osteoporosis | 4 (10) | 0 | 0 | 1.00 |
| Rheumatoid | 1 (2.5) | 0 | 0 | 0.033 |
| Arthritis | 1 (2.5) | 0 | 0 | 1.00 |
| Thyroid disease | 1.00 | |||
| Smoking history | ||||
| Ex‐smoker | 2 (6.5) | 6 (16.2) | 0 | |
| Never smoked | 29 (93.5) | 25 (67.6) | 18 (100)** | 0.007 |
| Shisha | 0 | 1 (2.7) | 0 | |
| Cigarette | 0 | 5 (13.5) | 0 | |
Frequencies presented as n (%). *Significant difference compared with control; **significant difference compared with group education; significant at P < 0.05.
CG, control group; GEP, group educational program; WEP, WhatsApp educational program.
Glycated hemoglobin and other biochemical changes in completing participants before and after 6‐month intervention
| Parameter | CG ( | GEP ( | WEP ( |
| ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Before | After |
| Before | After |
| Before | After |
| ||
| HbA1c | 6.0 ± 0.37 | 5.7 ± 0.49 | <0.001 | 6.0 ± 0.2 | 5.5 ± 0.54 | <0.001 | 6.0 ± 0.26 | 5.3 ± 0.51 | <0.001 | 0.33 |
| Glucose (mmol/L) | 5.4 ± 1.7 | 5.2 ± 0.88 | 0.06 | 6.0 ± 1.2 | 5.3 ± 1.0 | 0.001 | 5.7 ± 1.0 | 5.9 ± 1.2 | 0.62 | 0.71 |
| Triglycerides (mmol/L) | 1.5 ± 0.93 | 1.4 ± 0.7 | 0.03 | 3.7 ± 2.0 | 2.3 ± 1.3 | <0.001*** | 1.2 ± 0.52 | 1.1 ± 0.57 | 0.58***,**** | <0.001 |
| Total cholesterol (mmol/L) | 5.7 ± 2.2 | 5.2 ± 1.1 | 0.06 | 6.2 ± 1.4 | 5.0 ± 0.83 | 0.001 | 5.7 ± 1.1 | 5.6 ± 1.4 | 0.62 | 0.71 |
| HDL cholesterol (mmol/L) | 1.2 ± 0.43 | 1.2 ± 0.49 | 0.24 | 1.2 ± 0.55 | 1.6 ± 0.75 | 0.002 | 1.27 ± 0.31 | 1.3 ± 0.33 | 0.48 | 0.50 |
| LDL cholesterol (mmol/L) | 3.8 ± 2.0 | 3.4 ± 0.9 | 0.08 | 3.3 ± 1.8 | 2.3 ± 1.4 | 0.006 | 3.9 ± 1.0 | 3.8 ± 1.1 | 0.55**** | 0.001 |
Data presented as the mean ± standard deviation. *P‐value for paired t‐test; **P‐value for repeated measures ancova adjusted for age, baseline body mass index and marital status; ***significant difference compared with control; ****significant difference compared with group education; significant at P < 0.05.
CG, control group; GEP, group educational program; HbA1c, glycated hemoglobin; HDL, high‐density lipoprotein; LDL, high‐density lipoprotein; WEP, WhatsApp educational program.
Weight and other anthropometric changes in completing participants over time
| Parameter | CG ( | GEP ( | WEP ( |
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 3 | 6 |
| 0 | 3 | 6 |
| 0 | 3 | 6 |
| ||
| Weight (kg) | 75.9 ± 12.7 | 75.5 ± 12.2 | 75.7 ± 12.4 | 0.23 | 90.6 ± 27.3 | 86.1 ± 25.2 | 84.8 ± 24.3 | <0.01*** | 74.5 ± 13.8 | 74.3 ± 14 | 73.2 ± 13.8 | 0.044*** | 0.003 |
| BMI (kg/m2) | 31.6 ± 5.8 | 31.4 ± 5.6 | 31.5 ± 5.7 | 0.22 | 34.8 ± 9.0 | 33.2 ± 8.6 | 32.7 ± 8.3 | <0.01 | 30 ± 5.1 | 29.9 ± 5.1 | 29.4 ± 5.1 | 0.027**** | 0.02 |
| Waist (cm) | 93.2 ± 11.3 | 93.3 ± 10.6 | 93.4 ± 10.3 | 1.00 | 100 ± 19.1 | 98.6 ± 18.1 | 96.5 ± 17.8 | <0.01 | 89.9 ± 12.3 | 90.7 ± 12.6 | 88.8 ± 12.3 | 0.007**** | 0.017 |
| SBP (mmHg) | 126 ± 10.9 | 126 ± 11.3 | 126 ± 11.5 | 1.00 | 110 ± 31.2 | 106.4 ± 27 | 104.4 ± 25 | <0.01*** | 117.9 ± 9.4 | 119.7 ± 8.4 | 118.3 ± 7.2 | 0.81**** | <0.01 |
| DBP (mmHg) | 82.9 ± 8.5 | 81 ± 8.3 | 82.6 ± 8.6 | 0.39 | 103 ± 23.4 | 101.4 ± 25 | 98.4 ± 25 | <0.01* | 77.1 ± 7.1 | 73.2 ± 13.8 | 77.4 ± 6.6 | 1.00***,**** | <0.01 |
Data presented as the mean ± standard deviation; 0, 3 and 6 are months of intervention. *P‐value for repeated measures ancova adjusted for age, baseline body mass index (BMI) and marital status; **P‐value for one‐way ancova; ***significant difference compared with control; ****significant difference compared with group education; significant at P < 0.05.
CG, control group; DBP, diastolic blood pressure; GEP, group educational program; SBP, systolic blood pressure; WEP, WhatsApp educational program; WHR, waist‐to‐hip ratio.
Macronutrient changes in participants before and after the 6‐month intervention
| Parameter | CG | GEP | WEP |
| |||
|---|---|---|---|---|---|---|---|
| Before | After | Before | After | Before | After | ||
| Energy (Kcal) | 3,018.5 ± 828.8 | 2,800.3 ± 733.9** | 2,489.0 ± 805.6 | 1,746 ± 478.5**,*** | 2414.2 ± 946.2 | 2,297.4 ± 915.8** | 0.005 |
| Carbohydrate (g) | 322.9 ± 123.9 | 312.2 ± 120.0 | 308.6 ± 102.3 | 280.3 ± 98.9** | 253.8 ± 107.4 | 248.6 ± 107.1** | 0.066 |
| CHO energy (%) | 47.0 ± 7.4 | 48.1 ± 9.6 | 50.6 ± 11.3 | 51.9 ± 7.7 | 41.8 ± 5.0 | 43.0 ± 5.1**,***,**** | <0.001 |
| Protein (g) | 104.9 ± 35.7 | 103.6 ± 33.8 | 173.7 ± 126.9 | 151.2 ± 111.4**,*** | 123.2 ± 69.1 | 115.7 ± 64.7** | 0.036 |
| Protein Energy (%) | 16.1 ± 5.23 | 17.0 ± 5.8*,**** | 25.6 ± 10.7 | 25.0 ± 6.4 | 19.6 ± 5.4 | 19.4 ± 5.3**** | <0.001 |
| Fat (g) | 108.9 ± 40.7 | 98.7 ± 40.6*,**** | 62.2 ± 19.4 | 52.7 ± 14.2** | 99.9 ± 35.0 | 92.7 ± 33.5**,**** | <0.001 |
| Fat energy (%) | 36.9 ± 7.9 | 34.9 ± 8.0 | 24.2 ± 9.1 | 23.2 ± 5.1*** | 38.5 ± 5.3 | 37.6 ± 6.4**,***,**** | <0.001 |
| Fiber (g) | 24.8 ± 13.8 | 24.5 ± 11.0 | 25.6 ± 14.8 | 23.3 ± 13.2 | 24.9 ± 12.1 | 23.3 ± 8.5 | 0.54 |
Data presented as the mean ± standard deviation. P** denotes P‐value for repeated measures ancova adjusted for age, baseline body mass index and marital status; *P‐value < 0.05; **P‐value < 0.01; ***significant difference compared with control; ***significant difference compared with group education; significant at P < 0.05.
CG, control group; CHO, carbohydrates; GEP, group educational program; WEP, WhatsApp educational program.